Showing results (121-130 of 938) with videos related to

Sort By:
Pageof 94
Neuropharmacology|August 1, 1987
Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the ratM Hong, G J Kilpatrick, P Jenner, et al.
Neuropharmacology|May 1, 1988
The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the ratM Hong, E J Roots, P Jenner, et al.
Biochemical Pharmacology|July 7, 1992
Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervationK L Thomas, S Rose, P Jenner, et al.
Neuroscience Letters|April 6, 1984
Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazineR Kerwin, N M Rupniak, P Jenner, et al.
Psychopharmacology|January 1, 1991
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulationP Collins, C L Broekkamp, P Jenner, et al.
Neuropharmacology|April 1, 1987
In vitro characterisation of dopamine receptors in the superior colliculus of the ratM E Weller, S Rose, P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
P450 enzymes and Parkinson's disease: the story so farA G Riedl, P M Watts, P Jenner, et al.
Biochemical Pharmacology|June 1, 1984
Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neuronesS Boyce, E Kelly, C Reavill, et al.
Neuroscience Letters|October 12, 1992
Striatal neuropeptide levels in Parkinson's disease patientsA Fernandez, M L de Ceballos, P Jenner, et al.
Psychopharmacologia|January 1, 1975
Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsA Dolphin, P Jenner, C D Marsden, et al.
Pageof 94